Gemeniano, Hermenio Jr F.

HRN: 27-82-14  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/13/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/13/2026
08/20/2026
IV
1g
Q72
K Pneumoniae Carbapenemase Producing
Pending Pharmacy Acceptance 

 Indication:  Empiric Then Culture-directed    Type of Infection:  PneumoniaMultiple Infections (tick All Sites)    Compliance to guidelines: